Healthcare News and Research

Latest Healthcare News and Research

New UC Davis study suggests that popular molecular tests over-diagnose C. difficile infections

Clostridium difficile is a common cause of infection and diarrhea in hospitalized patients, but a new study by UC Davis pathologists suggests that many patients are mistakenly diagnosed and do not need antibiotic treatment. As a result, patients are likely being over-diagnosed and over-treated, adding to concerns about antibiotic resistance, damage to the "good" bacteria that live in people's intestines, and increased health-care costs.

9 Sep 2015

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing and commercializing innovative pain treatments, today announced the launch of OXAYDO (oxycodone HCI, USP) tablets -CII in the United States.

9 Sep 2015

New study reveals conflicting role of two subtypes of pancreatic cancer stroma

Dense surrounding tissue can block drugs from reaching pancreatic cancer tumors, but it can also help prevent the cancer from spreading. Now a new study by UNC Lineberger Comprehensive Cancer Center researchers and collaborators helps explain the conflicting role of the surrounding tissue known as stroma. In the study, the researchers revealed that based on molecular characteristics, there are two subtypes of pancreatic cancer stroma.

9 Sep 2015

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure (CHF).

9 Sep 2015

New book provides roadmap to improve health of U.S. citizens

The U.S. is one of the wealthiest nations in the world but its citizens are far from the healthiest. In fact, the U.S. lags behind several other developed nations in life expectancy and other population health measures. These disparities persist despite the fact that the U.S. spends more money per capita than any other nation on healthcare delivery.

9 Sep 2015

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.

8 Sep 2015

Mylan releases generic version of Yasmin Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, which is the generic version of Bayer's Yasmin Tablets. Mylan's partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for use by women to prevent pregnancy.

8 Sep 2015

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

8 Sep 2015

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.

8 Sep 2015

DCR launches Biospecimen Research Grant Program

DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.

8 Sep 2015

Demand for improved capabilities, wireless connectivity drives Western and Eastern European MPM market

As the Western European multiparameter patient monitor (MPM) market is in its mature stage, it will generate most of its revenues from replacement units. On the other hand, the Eastern European market, which has not reached maturity, will predominantly see new MPM installations.

8 Sep 2015

Johnson & Johnson wins Healthiest Company and Healthiest Workforce awards

Johnson & Johnson has been named Britain’s Healthiest Company and recognised as having Britain’s Healthiest Workforce which following the UK’s largest wellness survey, whose findings were validated by a research team at the University of Cambridge.

8 Sep 2015

Antibiotic resistance awareness: an interview with Professor Colin Garner

The threat of antibiotic resistance is very real. It is estimated that 700,000 people die each from resistant infections. In Europe the figure is 25,000 deaths and a similar number in the USA.

7 Sep 2015

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

A symposium on optimising insulin pump therapy, particularly focused on infusion set failures, will be held in advance of the 51st European Association for the Study of Diabetes Annual Meeting on 14th September 2015 in Stockholm.

7 Sep 2015

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun enrollment in the SHIELD II U.S. clinical trial examining the HeartMate PHP in patients undergoing a high-risk PCI (percutaneous coronary intervention) procedure.

4 Sep 2015

WPA launches first ever global campaign to achieve fairness in mental healthcare

The World Psychiatric Association (WPA) is today launching the first ever 'World Mind Matters Day', a global campaign with the main goal of achieving fairness in mental healthcare for all.

4 Sep 2015

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

4 Sep 2015

Inhibiting key protein involved in glucose production may help in treating type 2 diabetes

Some treatments for type 2 diabetes make the body more sensitive to insulin, the hormone that lowers blood sugar. But new research at Washington University School of Medicine in St. Louis suggests a different strategy: slowing the production of glucose in the liver.

4 Sep 2015

TXA drug reduces blood transfusion, saves costs

Using an inexpensive drug for every hip or knee replacement since 2013 has helped St. Michael's Hospital reduce its number of red blood cell transfusions performed during these surgeries by more than 40 per cent without negatively affecting patients, according to new research.

4 Sep 2015

Free e-book provides advice for lowering breast cancer risk at every stage of life

Surprisingly, preventing breast cancer can begin as early as age 2. Eating right, being physically active and keeping weight in check - even at a young age - can substantially lower breast cancer risk.

4 Sep 2015

Healthcare News and Research

Latest Healthcare News and Research

New UC Davis study suggests that popular molecular tests over-diagnose C. difficile infections

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

New study reveals conflicting role of two subtypes of pancreatic cancer stroma

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

New book provides roadmap to improve health of U.S. citizens

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Mylan releases generic version of Yasmin Tablets in the U.S.

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

IRIDEX launches novel intra-ocular pressure monitoring device

DCR launches Biospecimen Research Grant Program

Demand for improved capabilities, wireless connectivity drives Western and Eastern European MPM market

Johnson & Johnson wins Healthiest Company and Healthiest Workforce awards

Antibiotic resistance awareness: an interview with Professor Colin Garner

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

WPA launches first ever global campaign to achieve fairness in mental healthcare

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Inhibiting key protein involved in glucose production may help in treating type 2 diabetes

TXA drug reduces blood transfusion, saves costs

Free e-book provides advice for lowering breast cancer risk at every stage of life

Event guide: 3rd Measuring Patient Engagement Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Healthcare News and Research

Latest Healthcare News and Research

Event guide: 3rd Measuring Patient Engagement Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in